Literature DB >> 9818995

The effect of time and temperature variables on routine coagulation tests.

D Adcock1, D Kressin, R A Marlar.   

Abstract

This study evaluates the effects of time and temperature variables on routine coagulation assays [Prothrombin Time test and Activated Partial Thromboplastin Time (APTT) test]. Four different groups were studied: healthy volunteers, hospitalized patients not receiving anticoagulants, patients receiving oral anticoagulant therapy and patients receiving unfractionated heparin therapy. Samples were subjected to one of four conditions: (1) centrifuged immediately and stored at room temperature (20-22 degrees C); (2) centrifuged immediately and stored on ice (4 degrees C); (3) stored as whole blood without centrifugation, at room temperature and (4) stored without centrifugation, on ice. Coagulation tests were performed as soon as possible after phlebotomy and at specified times up to 24 h. Our data demonstrate that prothrombin time results are stable for up to 24 h, remaining constant regardless of storage conditions. APTT assays are stable for up to 8 h, except for patients receiving unfractionated heparin therapy. Heparinized samples, when stored uncentrifuged at room temperature, demonstrate a clinically significant shortening of the APTT and individual samples demonstrate a greater than 50% decrease in ex-vivo heparin levels at 4 h.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9818995     DOI: 10.1097/00001721-199809000-00002

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  5 in total

1.  Is citrate theophylline adenosine dipyridamole (CTAD) better than citrate to survey unfractionated heparin treatment? Has delayed centrifugation a real impact on this survey?

Authors:  Paul Billoir; Thomas Clavier; Arnaud Guilbert; Virginie Barbay; Marie Hélène Chrétien; Marielle Fresel; Caroline Abriou; Christophe Girault; Véronique Le Cam Duchez
Journal:  J Thromb Thrombolysis       Date:  2019-08       Impact factor: 2.300

2.  Assessment of Stability of Prothrombin Time, International Normalized Ratio, and Activated Partial Thromboplastin Time Under Different Storage Conditions in Human Plasma.

Authors:  Parag Patil; Tushar Sehgal; Priyanka Goswami; Malvika Gaur; Maroof Khan; Shivam Pandey; Sudip K Datta
Journal:  Cureus       Date:  2022-01-15

3.  Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaques.

Authors:  Clarisse Lorin; Lawrence Segal; Johann Mols; Danielle Morelle; Patricia Bourguignon; Olga Rovira; Pascal Mettens; Jérémy Silvano; Nicolas Dumey; Frédérick Le Goff; Marguerite Koutsoukos; Gerald Voss; Frédéric Tangy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-09-16       Impact factor: 3.000

4.  Prothrombin Time and Activated Partial Thromboplastin Time Testing: A Comparative Effectiveness Study in a Million-Patient Sample.

Authors:  Manu N Capoor; Jerry L Stonemetz; John C Baird; Fahad S Ahmed; Ahsan Awan; Christof Birkenmaier; Mario A Inchiosa; Steven K Magid; Kathryn McGoldrick; Ernesto Molmenti; Sajjad Naqvi; Stephen D Parker; S M Pothula; Aryeh Shander; R Grant Steen; Michael K Urban; Judith Wall; Vincent A Fischetti
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

5.  Effects of storage time and temperature on coagulation tests and factors in fresh plasma.

Authors:  Limin Feng; Ying Zhao; Hongcan Zhao; Zhexin Shao
Journal:  Sci Rep       Date:  2014-01-27       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.